1195 / 1816
L’association aux traitements systémiques
0
0.1
0.2
0.3
Cumulative incidence
0 3 6 9 12 15 18 21 24 27 30
Months
Concurrent arm (A)
CD8 > 16%
CD8 < 16%
0 3 6 9 12 15 18 21 24 27 30
Months
Sequential arm (B)
CD8 > 16%
CD8 < 16%
Subcutaneous fibrosis and RILA
0
0.1
0.2
0.3
Azria et al. Lancet Oncol 2010